Last updated on September 2018

Merestinib on Bone Metastases in Subjects With Breast Cancer

Brief description of study

This is a single arm, open label, pharmacodynamics, intrapatient dose escalation phase 1B study.

Clinical Study Identifier: NCT03292536

Contact Investigators or Research Sites near you

Start Over

Adam Cohen, MD

Huntsman Cancer Institute
Salt Lake City, UT United States
  Connect »